This study is currently not recruiting participants.

Determination of the Prevalence of Mycoplasma genitalium in Patients Receiving Diagnostic or Surveillance Testing for Gonorrhea and Chlamydia.

Study on Prevalence of Mycoplasma genitalium Bacteria in Patient Samples

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

We propose to determine the prevalence of M. genitalium in our patient population by analysis of remnant urogenital tract specimens submitted to the Division of Molecular Pathology at the Indiana University Health Pathology Laboratory (IUHPL) for standard-of-care gonococcal and chlamydial testing. To do so, we will test 1,500 remnant clinical samples, including urine and other urogenital tract specimen types, submitted in Aptima? transport solution (Hologic, Inc., Marlborough, MA), by the Aptima? Mycoplasma genitalium Assay on the fully automated Panther? (Hologic) system.

Detailed description of study

We propose to determine the prevalence of M. genitalium in our patient population by analysis of remnant urogenital tract specimens submitted to the Division of Molecular Pathology at the Indiana University Health Pathology Laboratory (IUHPL) for standard-of-care gonococcal and chlamydial testing. To do so, we will test 1,500 remnant clinical samples, including urine and other urogenital tract specimen types, submitted in Aptima? transport solution (Hologic, Inc., Marlborough, MA), by the Aptima? Mycoplasma genitalium Assay on the fully automated Panther? (Hologic) system.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: gonorrhea,chlamydia
  • Age: 100 years or below
  • Gender: All

This study investigates the prevalence of Mycoplasma genitalium, a type of bacteria, in patients by analyzing leftover samples from urogenital testing. The purpose of this study is to understand how common this bacteria is among patients who are tested for gonorrhea and chlamydia.

The study will involve testing 1,500 leftover clinical samples, which include urine and other types of urogenital samples. These samples will be tested using a specific method called the Aptima Mycoplasma genitalium Assay, which is performed on an automated system.

  • Who can participate: There are no specific requirements for participation as samples are leftover from routine tests.
  • Study details: Participants do not need to take any action as the study uses leftover samples from routine tests.
Updated on 19 Feb 2024. Study ID: 1711961506

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team